ArticleThe Journal of infection2015
Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistance.
Article in The Journal of infection, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Occurrence and Antimicrobial Resistance ofFoods (Basel, Switzerland) · 2026Article
- Phage-antibiotic synergy attenuatesFrontiers in cellular and infection microbiology · 2026Article
- Clinical Implications of Bacteremia Caused by Non-Biomedicines · 2025Article
- Phenotypical and Molecular Characterization ofLife (Basel, Switzerland) · 2025Article
- Review
- Article
- Identification and characterization of the capsule depolymerase Dpo27 from phage IME-Ap7 specific toFrontiers in cellular and infection microbiology · 2024Article
- A bioinformatic approach to identify confirmed and probable CRISPR-Cas systems in theFrontiers in microbiology · 2024Article
- Antimicrobial Susceptibility Profiles ofVeterinary sciences · 2023Article
- Article
- Genomic landscape of prominent XDR Acinetobacter clonal complexes from Dhaka, Bangladesh.BMC genomics · 2022Article
- Emergence and multi-lineages of carbapenemase-producing Acinetobacter baumannii-calcoaceticus complex from canine and feline origins.The Journal of veterinary medical science · 2022Article
- An Update on Wastewater Multi-Resistant Bacteria: Identification of Clinical Pathogens Such asMicroorganisms · 2021Article
- Epidemiology and clinical outcomes associated with extensively drug-resistant (XDR)Infection control and hospital epidemiology · 2021Article
- Advances in automated techniques to identifyAsian biomedicine : research, reviews and news · 2020Review
- Article
- Genetic Diversity of Imipenem-ResistantCritical care research and practice · 2020Article
- Chromosome Architecture and Gene Content of the Emergent PathogenFrontiers in microbiology · 2020Article
- Accurate identification of clinically importantFuture science OA · 2019Review
- A Genomic Approach To Identify Klebsiella pneumoniae and Acinetobacter baumannii Strains with Enhanced Competitive Fitness in the Lungs during Multistrain Pneumonia.Infection and immunity · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesBacteria within the Acinetobacter calcoaceticus-Acinetobacter baumannii (ACB) complex commonly cause nosocomial infection and are often multidrug resistant. Advances in genospecies typing allow for speciation within the ACB complex; however, little is known about the effect of genospecies on patient outcomes.
methodsAdult patients with ACB complex bacteremia from Jan 2005-Oct 2012 were included. Bacterial isolates were speciated by rpoB gene sequence analysis, and clinical data were collected.
resultsOf 147 patients with ACB complex bacteremia, 116 had A. baumannii (78.9%), 28 had Acinetobacter pittii (19.0%), and 3 had Acinetobacter nosocomialis (2.0%). A. baumannii bacteremia was associated with greater comorbidity and was more frequently multidrug resistant (79% vs. 16%, p < 0.01). Multidrug resistant A. baumannii but not susceptible A. baumannii was associated with worse outcomes compared to non-baumannii ACB complex bacteremia. Neither multidrug resistance nor genospecies was an independent predictor of mortality, but receipt of appropriate therapy was associated with decreased risk of mortality (OR, 0.13; 95% CI, 0.04-0.44; p < 0.01).
conclusionsA. baumannii bacteremia is associated with worse clinical outcomes than non-baumannii ACB complex bacteremia. The difference, however, appears to be related to multidrug resistance and attendant receipt of appropriate therapy rather than genospecies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.